STABILITY TESTING OF DRUG SUBSTANCES AND DRUG PRODUCTS

This ICH guideline outlines the stability data expectations for drug substances and drug products.  This guideline is applicable to marketed drug products, including those associated with registration and lifecycle/post-approval changes and, when applicable, master files.